Explicit versus implicit evaluation to detect inappropriate medication use in geriatric outpatients

被引:8
作者
Bahat, Gulistan [1 ]
Ilhan, Birkan [2 ]
Bay, Ilker [3 ]
Kilic, Cihan [1 ,3 ]
Kucukdagli, Pinar [1 ,3 ]
Oren, Meryem Merve [4 ]
Karan, Mehmet Akif [1 ,3 ]
机构
[1] Istanbul Univ, Istanbul Med Sch, Dept Internal Med, Div Geriatr, Istanbul, Turkey
[2] Dr Ersin Arslan Training & Res Hosp, Dept Internal Med, Div Geriatr, Gaziantep, Turkey
[3] Istanbul Univ, Istanbul Med Sch, Dept Internal Med, TR-34390 Istanbul, Turkey
[4] Publ Hlth Serv Presidency, Erzurum Prov Hlth Directorate, Erzurum, Turkey
关键词
Comparison; explicit criteria; implicit evaluation; inappropriate medication; polypharmacy; ADVERSE DRUG-REACTIONS; POTENTIALLY INAPPROPRIATE; OLDER-ADULTS; SCREENING TOOL; CRITERIA; MANAGEMENT; INHIBITORS; AGITATION; ILLNESS; BEERS;
D O I
10.1080/13685538.2018.1464552
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: The rates and reasons why clinicians decide not to follow recommendations from explicit-criteria have been studied scarce. We aimed to compare STOPP version 2 representing one of the most commonly used excplicit tool with the implicit comprehensive geriatric assessment mediated clinical evaluation considered as gold standard. Methods: Two hundred and six (n = 206) outpatients >= 65 years old were included. The study was designed as retrospective, cross-sectional, and randomised. STOPP version 2 criteria were systematically used to assess pre-admission treatments followed by implicit clinical evaluation regarding two questions: Were the STOPP criteria recommendations valid for the individual patient and were there any potentially inappropriate-prescription other than depicted by STOPP version 2 criteria? The underlying reason(s) and associated clinical-features were noted. Results: About 62.6% potentially inappropriate-prescriptions were identified (0.6 per-subject) according to systematic application of STOPP v2 while it was 53.4% (0.5 potentially inappropriate-prescriptions per subject) by clinician's application of STOPP v2. Prevalence of non-compliance was 14.7% in 18 (21.7%) of 83 patients identified by systematic application. Suggestion to stop a drug was not accepted because of need of treatment despite likelihood of anticipated side-effects in about 2/3 and with no-anticipated side-effects in about 1/3 of non-compliances. Not following STOPP v2 was significantly associated with lower functional level. According to clinician's implicit-evaluation, there were an extra 59.2% potentially inappropriate-prescriptions (0.6 per subject) in 80 (38.8%) patients yielding a total of 112.6% potentially inappropriate-prescription. Conclusions: Most of the STOPP v2 directed drug cessations are decided valid by the clinicians. In patients with higher functional dependency, it is likely that they are not followed due to palliation focussed care/patient-family preferences. There may be as much as STOPP v2 identified potentially inappropriate-prescriptions by implicit evaluation in a significant percent of geriatric patients signifying need for comprehensive geriatric evaluation in practice.
引用
收藏
页码:179 / 184
页数:6
相关论文
共 25 条
  • [1] Prevalence of potentially inappropriate prescribing among older adults: A comparison of the Beers 2012 and Screening Tool of Older Person's Prescriptions criteria version 2
    Bahat, Gulistan
    Bay, Ilker
    Tufan, Asli
    Tufan, Fatih
    Kilic, Cihan
    Karan, Mehmet Akif
    [J]. GERIATRICS & GERONTOLOGY INTERNATIONAL, 2017, 17 (09) : 1245 - 1251
  • [2] Management of agitation and aggression associated with Alzheimer disease
    Ballard, Clive G.
    Gauthier, Serge
    Cummings, Jeffrey L.
    Brodaty, Henry
    Grossberg, George T.
    Robert, Philippe
    Lyketsos, Constantine G.
    [J]. NATURE REVIEWS NEUROLOGY, 2009, 5 (05) : 245 - 255
  • [3] Reasons for non-use of proven pharmacotherapeutic interventions: systematic review and framework development
    Barry, Arden R.
    Loewen, Peter S.
    de Lemos, Jane
    Lee, Karen G.
    [J]. JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2012, 18 (01) : 49 - 55
  • [4] Inappropriate medication use and prescribing indicators in elderly Australians
    Basger, Benjamin J.
    Chen, Timothy F.
    Moles, Rebekah J.
    [J]. DRUGS & AGING, 2008, 25 (09) : 777 - 793
  • [5] Predictive Validity of the Beers and Screening Tool of Older Persons' Potentially Inappropriate Prescriptions (STOPP) Criteria to Detect Adverse Drug Events, Hospitalizations, and Emergency Department Visits in the United States
    Brown, Joshua D.
    Hutchison, Lisa C.
    Li, Chenghui
    Painter, Jacob T.
    Martin, Bradley C.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2016, 64 (01) : 22 - 30
  • [6] Functional Status and Antihypertensive Therapy in Older Adults: A New Perspective on Old Data
    Charlesworth, Christina J.
    Peralta, Carmen A.
    Odden, Michelle C.
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 2016, 29 (06) : 690 - 695
  • [7] The association between chronic illness and functional change among participants in a comprehensive geriatric assessment program
    Cho, CY
    Alessi, CA
    Cho, M
    Aronow, HU
    Stuck, AE
    Rubenstein, LZ
    Beck, JC
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1998, 46 (06) : 677 - 682
  • [8] Inappropriate Medication Use as a Risk Factor for Self-Reported Adverse Drug Effects in Older Adults
    Chrischilles, Elizabeth A.
    VanGilder, Rachel
    Wright, Kara
    Kelly, Michael
    Wallace, Robert B.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2009, 57 (06) : 1000 - 1006
  • [9] Interventions to improve the appropriate use of polypharmacy in older people: a Cochrane systematic review
    Cooper, Janine A.
    Cadogan, Cathal A.
    Patterson, Susan M.
    Kerse, Ngaire
    Bradley, Marie C.
    Ryan, Cristin
    Hughes, Carmel M.
    [J]. BMJ OPEN, 2015, 5 (12):
  • [10] Individualisation of drug treatments for patients with long-term conditions: a review of concepts
    Denford, S.
    Frost, J.
    Dieppe, P.
    Cooper, Chris
    Britten, N.
    [J]. BMJ OPEN, 2014, 4 (03):